Reservoir for aerosol delivery devices

Information

  • Patent Grant
  • 10349684
  • Patent Number
    10,349,684
  • Date Filed
    Monday, July 30, 2018
    6 years ago
  • Date Issued
    Tuesday, July 16, 2019
    5 years ago
Abstract
An aerosol delivery device or electronic cigarette generates an aerosol or vapor for consumption by a consumer. The device may include a cartridge holding an aerosol precursor substance or fluid that is turned into the aerosol or vapor. The fluid may be stored in reservoir that allows for the fluid to be passed to an atomizer for generating the aerosol. The reservoir may be a flexible bladder that equalizes pressure inside the cartridge to reduce leakage, such as with an internal valve to activate fluid transfer. Alternatively, the reservoir may include one or more capsules that can be broken or melted to release the fluid.
Description
TECHNICAL FIELD

The present disclosure relates to aerosol delivery devices such as personal vapor inhaling units, vaporizers, or smoking articles that may utilize electrically generated heat for the production of aerosol (e.g., smoking articles commonly referred to as electronic cigarettes). The smoking articles or vaporizers may be configured to heat an aerosol precursor substance (such as a formulation incorporating glycerin and nicotine) to form the aerosol for inhalation. This disclosure relates to a system and method for using a collapsible bladder or breakable capsule(s) that hold or contain the aerosol precursor. Of particular interest are products made or derived from tobacco, or that otherwise incorporate tobacco, and that are intended for human consumption.


BACKGROUND

Many smoking devices have been proposed through the years as improvements upon, or alternatives to, smoking products that require combusting tobacco for use. Many of those devices purportedly have been designed to provide the sensations associated with cigarette, cigar or pipe smoking, but without delivering considerable quantities of incomplete combustion and pyrolysis products that result from the burning of tobacco. To this end, there have been proposed numerous smoking products, flavor generators and medicinal inhalers that utilize electrical energy to vaporize or heat a volatile material, or attempt to provide the sensations of cigarette, cigar or pipe smoking without burning tobacco to a significant degree. See, for example, the various alternative smoking articles, aerosol delivery devices and heat generating sources set forth in the background art described in U.S. Pat. No. 7,726,320 to Robinson et al., U.S. Pat. App. Pub. No. 2013/0255702 to Griffith Jr. et al., and U.S. Pat. App. Pub. No. 2014/0096781 to Sears et al; which are incorporated herein by reference. See also, for example, the various types of smoking articles, aerosol delivery devices and electrically-powered heat generating sources referenced by brand name and commercial source in U.S. Pat. Pub. No. 2015/0216232 to Bless et al., which is incorporated herein by reference. Additionally, other types of smoking articles have been proposed in U.S. Pat. No. 5,505,214 to Collins et al.; U.S. Pat. No. 5,894,841 to Voges; U.S. Pat. No. 6,772,756 to Shayan; and U.S. Pat. App. Pub. Nos. 2006/0196518 to Hon; 2007/0267031 to Hon; 2014/0261495 to Novak III et al. and 2015/0230521 to Talon; which are incorporated herein by reference.


It would be desirable to provide an aerosol delivery device (such as an aerosol delivery smoking system common referred to as an electronic cigarette) that is capable of providing aerosol in the form of a vaporized substance in a consistent and pleasing manner. Thus, it would be desirable to provide an aerosol delivery device that has components or features that assist in regulating of amount of aerosol precursor available for vaporization, and hence controlling the amount of aerosol precursor available for vaporization and aerosol formation for inhalation.


SUMMARY

The present disclosure relates to aerosol delivery devices, methods of forming such devices, and elements of such devices. The aerosol delivery devices can provide for more consistent distribution of the aerosol precursor substance. When the amount of the aerosol precursor substance (i.e. liquid or e-liquid) is consistent, the smoking (i.e. vaping) experience may be most pleasing to the user. Consistency may be achieved by controlling the amount of liquid that is vaporized. However, the amount of liquid that is vaporized may vary as the volume of the liquid in the device changes. The fluid reservoir in the cartridge may have leakage caused by pressure or temperature changes which result in inconsistent control of the amount of liquid that is vaporized. Utilization of a flexible bladder or capsule may help to regulate and control the flow of the liquid.


In one embodiment, a cartridge assembly for an aerosol delivery device includes a flexible bladder that stores an aerosol precursor substance and a supporting tube that holds the flexible bladder. The assembly includes a plug at one end of the supporting tube that seals the flexible bladder to control leakage except for a porous portion of the plug that allows the aerosol precursor substance through.


In another embodiment, an electronic cigarette includes a battery portion and a cartridge that receives power from the battery portion and stores a fluid that is vaporized. The cartridge includes a flexible bladder holding the fluid, a tube supporting the flexible bladder, and a cap that seals the flexible bladder, wherein the cap includes a porous material for transporting the fluid from the bladder.


In another embodiment, vaporization device includes a mouthpiece for receiving air with vapor and a soft fluid bladder that stores a fluid and reduces excessive air by collapsing as the fluid is removed. The device includes support cylinder that supports the soft fluid bladder and a porous material cap that is disposed on one end of the support cylinder and coupled with the soft fluid bladder for leaking a controlled amount of the fluid. The device further includes an atomizer that generates the vapor from the fluid stored in the soft fluid bladder.


In another embodiment, an aerosol delivery device includes one or more capsules containing an aerosol precursor substance. A mechanism releases the aerosol precursor substance. The mechanism may cause a breaking or heating of the capsules. A vaporizer receives the aerosol precursor substance after the releasing and generates an aerosol by vaporizing the aerosol precursor substance.





BRIEF DESCRIPTION OF THE DRAWINGS

Having thus described the disclosure in the foregoing general terms, reference will now be made to the accompanying drawings, which are not necessarily drawn to scale, and wherein:



FIG. 1 illustrates an aerosol delivery device in a two piece assembly implementation.



FIG. 2 illustrates a cartridge for an aerosol delivery device including a bladder portion.



FIG. 3 illustrates a fluid container for a cartridge in an aerosol delivery device.



FIG. 4 illustrates the fluid container of FIG. 3 in a closed state.



FIG. 5 illustrates air flow in the cartridge.



FIG. 6 illustrates a sealed bladder in a cartridge for an aerosol delivery device.



FIG. 7 illustrates one embodiment of a sealing mechanism for sealing a bladder in a cartridge.



FIG. 8 illustrates an embodiment of a cartridge with a modified air path.



FIG. 9 illustrates an embodiment of an end of the cartridge in FIG. 8 with the modified air path.



FIG. 10 illustrates a cartridge with a valve connection.



FIG. 11 illustrates a closed state of the elastomeric valve shown in FIG. 10.



FIG. 12 illustrates an open state of the elastomeric valve shown in FIG. 10.



FIG. 13 illustrates another elastomeric valve.



FIG. 14 illustrates a sealed state of the cartridge.



FIG. 15 illustrates an open state of the cartridge.



FIG. 16 illustrates a cartridge for an aerosol delivery device including one or capsules.



FIG. 17 illustrates an alternative embodiment of capsules.



FIG. 18 illustrates an alternative cartridge for an aerosol delivery device including one or capsules disposed adjacent the heating element.



FIG. 19 illustrates a breaking mechanism for the capsules.





DESCRIPTION OF THE EMBODIMENTS

The present disclosure will now be described more fully hereinafter with reference to example implementations thereof. These example implementations are described so that this disclosure will be thorough and complete, and will fully convey the scope of the disclosure to those skilled in the art. Indeed, the disclosure may be embodied in many different forms and should not be construed as limited to the implementations set forth herein; rather, these implementations are provided so that this disclosure will satisfy applicable legal requirements. As used in the specification and the appended claims, the singular forms “a,” “an,” “the” and the like include plural referents unless the context clearly dictates otherwise.


As described hereinafter, example implementations of the present disclosure relate to aerosol delivery systems. As used herein, an aerosol delivery system may include an electronic cigarette (“e-Cig”) or a personal vaporizing unit (“PVU”) that uses electrical energy to heat a material to form an inhalable substance. Unlike regular cigarettes, the byproduct generated by these devices is not a smoke, but rather an aerosol or a vapor resulting from the volatilization or vaporization of certain components incorporated therein. In some example implementations, components of aerosol delivery systems may be characterized as electronic cigarettes, and those electronic cigarettes most preferably incorporate tobacco and/or components derived from tobacco, and hence deliver tobacco derived components in aerosol form.


Aerosol generating pieces of certain preferred aerosol delivery systems may provide many of the sensations (e.g., inhalation and exhalation rituals, types of tastes or flavors, organoleptic effects, physical feel, use rituals, visual cues such as those provided by visible aerosol, and the like) of smoking a cigarette, cigar or pipe that is employed by lighting and burning tobacco (and hence inhaling tobacco smoke), without any substantial degree of combustion of any component thereof. For example, the user of an aerosol generating piece of the present disclosure can hold and use that piece much like a smoker employs a traditional type of smoking article, draw on one end of that piece for inhalation of aerosol produced by that piece, take or draw puffs at selected intervals of time, and the like.


Aerosol delivery systems of the present disclosure also can be characterized as being vapor-producing articles or medicament delivery articles. Thus, such articles or devices can be adapted so as to provide one or more substances (e.g., flavors and/or pharmaceutical active ingredients) in an inhalable form or state. For example, inhalable substances can be substantially in the form of a vapor (i.e., a substance that is in the gas phase at a temperature lower than its critical point). Alternatively, inhalable substances can be in the form of an aerosol (i.e., a suspension of fine solid particles or liquid droplets in a gas). For purposes of simplicity, the term “aerosol” as used herein is meant to include vapors, gases and aerosols of a form or type suitable for human inhalation, whether or not visible, and whether or not of a form that might be considered to be smoke-like.


Aerosol delivery devices of the present disclosure generally include a number of components provided within an outer body or shell, which may be referred to as a housing. The overall design of the outer body or shell can vary, and the format or configuration of the outer body that can define the overall size and shape of the aerosol delivery device can vary. For some aerosol delivery devices, an elongated body resembling the shape of a cigarette or cigar can be a formed from a single, unitary housing, or the elongated housing can be formed of two or more separable bodies. For example, an aerosol delivery device can comprise an elongated shell or body that can be substantially tubular in shape and, as such, resemble the shape of a conventional cigarette or cigar. In one implementation, all of the components of the aerosol delivery device are contained within a single housing. Alternatively, an aerosol delivery device can comprise two or more housings that are joined and are separable. For example, an aerosol delivery device can possess at one end a control body comprising a housing containing one or more reusable components (e.g., a rechargeable battery and various electronics for controlling the operation of that article), and at the other end and removably attached thereto an outer body or shell containing a portion including one or more aerosol precursor components, such as flavors and aerosol formers. In various implementations, this portion may be a disposable portion (e.g., a disposable cartridge) or a refillable portion (e.g., a refillable tank).


Embodiments of this application include a non-rigid tank with a flexible bladder for equalizing pressure and reducing leakage. In contrast with a more rigid tank, the flexible bladder is the ability to keep air out of the reservoir or vessel. If there were air in the vessel, heating/cooling or increases/decreases in pressure (which may be caused by expansion in the air volume) are avoided as the bladder is free to expand or contract. A rigid vessel may experiences a pressure differential between inside and outside the rigid tank, either forcing liquid and/or air out, or taking in air while it equalizes. The flexible bladder may prevent air from entering even when the fluid in the bladder is removed. The bag may be in a collapsed or deflated state. With a flexible bladder, the cartridge may be disposable.


Aerosol delivery devices of the present disclosure can be formed of an outer housing or shell that is not substantially tubular in shape but may be formed to substantially greater dimensions. The housing or shell can be configured to include a mouthpiece and/or may be configured to receive a separate shell (e.g., a cartridge, a tank) that can include consumable elements, such as a liquid aerosol former, and can include a vaporizer.


Aerosol delivery systems of the present disclosure most preferably comprise some combination of a power source (i.e., an electrical power source), at least one control component (e.g., means for actuating, controlling, regulating and ceasing power for heat generation, such as by controlling electrical current flow from the power source to other components of the article—e.g., a microprocessor, individually or as part of a microcontroller), a heater or heat generation member (e.g., an electrical resistance heating element or other component, which alone or in combination with one or more further elements may be commonly referred to as an “atomizer”), an aerosol precursor composition (e.g., commonly a liquid capable of yielding an aerosol upon application of sufficient heat, such as ingredients commonly referred to as “smoke juice,” “e-liquid” and “e-juice”), and a mouth end region or tip for allowing draw upon the aerosol delivery device for aerosol inhalation (e.g., a defined airflow path through the article such that aerosol generated can be withdrawn therefrom upon draw).


More specific formats, configurations and arrangements of components within the aerosol delivery systems of the present disclosure will be evident in light of the further disclosure provided hereinafter. Additionally, the selection and arrangement of various aerosol delivery system components can be appreciated upon consideration of the commercially available electronic aerosol delivery devices, such as those representative products referenced in background art section of the present disclosure.



FIG. 1 illustrates an aerosol delivery device in a two piece assembly implementation. In the exemplary two piece assembly, there is a distal end (distal assembly) and a proximal end (proximal assembly). The distal assembly may be referred to as a control body and may include the battery and microprocessor. The proximal assembly may be referred to as the tank and may include the cartridge (with fluid reservoir) and atomizer. Although not shown, the distal assembly interfaces with the proximal assembly by a connection interface such that energy from a power source such as a battery or capacitor may be transmitted to the proximal assembly. Examples of batteries that can be used according to the disclosure are described in U.S. Pat. Pub. No. 2010/0028766 to Peckerar et al., the disclosure of which is incorporated herein by reference in its entirety.


The aerosol delivery device may incorporate a sensor or detector for control of supply of electric power to a heater when aerosol generation is desired (e.g., upon draw during use). As such, for example, there is provided a manner or method of turning off the power supply to the heater when the aerosol delivery device is not being drawn upon during use, and for turning on the power supply to actuate or trigger the generation of heat by the heater during draw. Additional representative types of sensing or detection mechanisms, structure and configuration thereof, components thereof, and general methods of operation thereof, are described in U.S. Pat. No. 5,261,424 to Sprinkel, Jr., U.S. Pat. No. 5,372,148 to McCafferty et al., and PCT Pat. App. Pub. No. WO 2010/003480 to Flick, all of which are incorporated herein by reference in their entireties.


The distal assembly may include a main body that houses a battery or capacitor, one or a plurality of microprocessors, an LED or light at the distal aspect of the device. The distal assembly or battery portion may include a number of electronic components, and in some examples may be formed of an electronic or printed circuit board (PCB) that supports and electrically connects the electronic components. The electronic components may include a microprocessor or processor core, and a memory. In some examples, the control component may include a microcontroller with integrated processor core and memory, and which may further include one or more integrated input/output peripherals. In some examples, the control component may be coupled to a communication interface to enable wireless communication with one or more networks, computing devices or other appropriately-enabled devices. Examples of suitable communication interfaces are disclosed in U.S. patent application Ser. No. 14/638,562, filed Mar. 4, 2015, to Marion et al., the content of which is incorporated by reference in its entirety. And examples of suitable manners according to which the aerosol delivery device may be configured to wirelessly communicate are disclosed in U.S. patent application Ser. No. 14/327,776, filed Jul. 10, 2014, to Ampolini et al., and U.S. patent application Ser. No. 14/609,032, filed Jan. 29, 2015, to Henry, Jr. et al., each of which is incorporated herein by reference in its entirety.


The distal assembly may connect with the cartridge connector on the proximal assembly. The proximal assembly may include an atomizer housing which houses a secondary wick and heating element or elements. The atomizer housing may include connections for integrating a microprocessor, the power source, and the heating element. The atomizer housing may also include a wick element that is in contact with the fluid to be vaporized. The fluid to be vaporized may be stored in a fluid reservoir. The atomizer housing and fluid reservoir may be disposed in a chamber housing, which also functions as the mouthpiece of the PVU.


In some example implementations, the proximal assembly or cartridge may be referred to as being disposable or as being reusable. In another example, the proximal assembly may have a replaceable battery or a rechargeable battery and thus may be combined with any type of recharging technology, including connection to a typical alternating current electrical outlet, connection to a car charger (i.e., a cigarette lighter receptacle), and connection to a computer, such as through a universal serial bus (USB) cable or connector. The proximal assembly may include a tank comprising a refillable reservoir. The reservoir may be configured to retain the aerosol precursor composition (e.g. fluid). The reservoir particularly may be formed of or coupled with a wick made of a porous material (e.g., a fibrous material). As described below with respect to FIG. 2-5, the cartridge may include a bladder for storing the fluid substance.



FIG. 2 illustrates a cartridge 200 for an aerosol delivery device including a bladder portion. The cartridge 200 may include an external tube or mouthpiece 202 and a bladder support cylinder 204 for supporting a liquid container bladder 206. The liquid container bladder 206 may be a reservoir that contains a fluid 208 or e-liquid that is the precursor substance to the aerosol. An aerosol precursor composition may be retained in the bladder 206. Liquid components, for example, can be retained by the bladder 206. The bladder 206 can be in a fluid connection through a plug 210. The plug 210 may cap the bladder 206 to hold the fluid 208. The plug 210 may be a silicone or ceramic material, but other materials may also be used, such as CA. The device shown is comprised of a ceramic center core with a silicone outer case that seals the perimeter from leakage, as the ceramic will let the fluid to migrate through onto the wick 214.


A flow-tube 212 or terminal support may be provided that includes or couples with a heater 214 (sometimes referred to as a heating element). The flow-tube 212 may allow air to flow through it and act as a terminal support element to support the heater 214. The heater 214 shown in FIG. 2 may be a wick that includes a coil wrapped around the wick. The wick receives fluid that is heated by the heater coil. The plug 210 and/or flow-tube 212 may be adapted to wick or otherwise transport a fluid stored in the bladder 206 to the heater 214. As shown, the center ceramic portion of the plug 210 can transport liquid to the wick. The heater 214 may be supported by the flow-tube 212, which acts as an inlet that air passes through.


A valve may be between the bladder 206 and a center ceramic of the plug 210. This may release fluid when the valve is activated. The flow-tube 212 might be used to activate the valve. The valve may be positioned between the fluid reservoir and the heater 214, and configured to control an amount of fluid passed or delivered from the reservoir to the heater. Various examples of materials configured to produce heat when electrical current is applied therethrough may be employed to form the heater 214. The heater in these examples may be resistive heating element such as a coil. Example materials from which the coil may be formed include Kanthal (FeCrAl), Nichrome, Molybdenum disilicide (MoSi2), molybdenum silicide (MoSi), Molybdenum disilicide doped with Aluminum (Mo(Si,Al)2), graphite and graphite-based materials (e.g., carbon-based foams and yarns) and ceramics (e.g., positive or negative temperature coefficient ceramics).


An end portion of the cartridge 200 may include a smart chip 216, a communication terminal 218, and a cartridge base 220. The smart chip 216 may include an integrated circuit, a memory component, a sensor, or the like. The electronic components of the smart chip 216 may be adapted to communicate using the communication terminal 218 with the distal assembly (battery portion) and/or with an external device by wired or wireless means.


In use, when a user draws on the aerosol delivery device, airflow is detected by a flow sensor (not shown), and the heater 214 is activated to vaporize components of the aerosol precursor composition. Drawing upon a mouthpiece 202 of the aerosol delivery device causes ambient air to enter the air intake and the drawn air combines with the formed vapor to form an aerosol. The aerosol is whisked, aspirated or otherwise drawn away from the heater around the bladder support cylinder 204 and out an opening in the mouthpiece 202 of the aerosol delivery device.


As described, the bladder 206 acts as a reservoir for a substance to be vaporized. That substance may be a liquid (i.e. e-liquid) or other fluid and may be referred to as an aerosol precursor composition or vapor precursor composition. The fluid may comprise a variety of components including, by way of example, a polyhydric alcohol (e.g., glycerin, propylene glycol, or a mixture thereof), nicotine, tobacco, tobacco extract, and/or flavorants. Representative types of aerosol precursor components and formulations also are set forth and characterized in U.S. Pat. No. 7,217,320 to Robinson et al. and U.S. Pat. Pub. Nos. 2013/0008457 to Zheng et al.; 2013/0213417 to Chong et al. and 2014/0060554 to Collett et al., the disclosures of which are incorporated herein by reference. Other aerosol precursors that may be employed include the aerosol precursors that have been incorporated in the VUSE® product by R. J. Reynolds Vapor Company, the BLU™ product by Lorillard Technologies, the MISTIC MENTHOL product by Mistic Ecigs, and the VYPE product by CN Creative Ltd. Also desirable are the so-called “smoke juices” for electronic cigarettes that have been available from Johnson Creek Enterprises LLC. Additional representative types of fluids are set forth in U.S. Pat. No. 4,793,365 to Sensabaugh, Jr. et al., U.S. Pat. No. 5,101,839 to Jakob et al., U.S. Pat. No. 6,779,531 to Biggs et al., U.S. Pat. App. Pub. No. 2013/0008457 to Lipowicz et al.; and 2015/0020830 to Koller, as well as WO 2014/182736 to Bowen et al, and Chemical and Biological Studies on New Cigarette Prototypes that Heat Instead of Burn Tobacco, R. J. Reynolds Tobacco Company Monograph (1988), all of which are incorporated herein by reference in their entireties.


The amount of fluid that is incorporated within the aerosol delivery system is such that the aerosol generating piece provides acceptable sensory and desirable performance characteristics. For example, it may be preferred that sufficient amounts of fluid (e.g., glycerin and/or propylene glycol), be employed in order to provide for the generation of a visible mainstream aerosol that in many regards resembles the appearance of tobacco smoke. The amount of fluid within the aerosol generating system may be dependent upon factors such as the number of puffs desired per aerosol generating piece. Typically, the amount of fluid incorporated within the aerosol delivery system, and particularly within the aerosol generating piece, is less than about 2 g, generally less than about 1.5 g, often less than about 1 g and frequently less than about 0.5 g. The flexible bladder 206 (and supporting components) may be re-sized in different embodiments for an optimal amount of fluid.



FIG. 3 illustrates a fluid container for a cartridge in an aerosol delivery device. The fluid container in FIG. 3 may be similar to the fluid container illustrated in FIG. 2. In particular, a flexible bladder 302 may be the same as or similar to the bladder 206 shown in FIG. 2. Likewise, a cap portion 306 may be the same as or similar to the cap 210 shown in FIG. 2. Finally, the tube 304 may be either the external tube 202 or bladder support cylinder 204 shown in FIG. 2.


The flexible bladder 302 may be a flexible bag or similar material. In one embodiment, the bladder 302 may be a latex material or a thin plastic. The flexibility of the bladder 302 may allow for pressure changes or temperature changes that would otherwise disrupt a sealed tank (i.e. non-flexible container), such as leakage. In particular, the flexible bladder 302 may equalize the pressure exterior to the reservoir and the inside pressure of the reservoir. The bladder 302 can adapt and adjusts for any pressure changes.


The seal of the bladder 302 may be a porous membrane within the cap 306. In other words, the cap 306 may form an elastomeric seal on the open end of the bladder. The tube 304 may be open-ended for allowing for expansion/contraction of the bladder 302. The cap 306 may be referred to as a plug or seal and provide a means for controlling and generating fluid flow from the bladder 302 to the heating element. Ceramic may be used for the cap 306 because it can be porous enough to allow a light fluid flow to a wick with the heating element. In particular, a silica wick may be in contact with a ceramic (or other porous material) in the cap 306 which receives fluid that is transported to or near the heating element. Other materials other than a ceramic may be utilized with the cap 306 that allow for fluid flow from the bladder 302. For example, cellulose acetate or a porous plastic may be used for the cap 306. The cap 306 may be encased in a silicone boot to prevent leakage except for a desired amount through the porous material of the cap 306.



FIG. 4 illustrates the fluid container of FIG. 3 in a closed state. In particular FIG. 4 illustrates the cap 406 coupled to a tube 404 to seal the bladder 402. The sealing of the bladder 402 prevents leakage of the fluid, but the cap 406 can still allow fluid flow from the bladder through a porous material 408. The porous material 408 may include a ceramic, plastic, or other porous material that weeps fluid from the bladder 402. The fluid may be held in the bladder and the air flow (from a user inhaling described with respect to FIG. 5) may trigger fluid flow from the bladder 302. The sealing of the bladder is further discussed below with respect to FIGS. 6-15. FIG. 4 illustrates the flexible nature of the bladder 402. In particular, the bladder 402 may collapse as fluid is dispensed from the bladder 402. The collapsed portion 403 of the bladder 402 results from the bladder not being as full as fluid is removed. The collapsing of the bladder 402 may serve to maintain a balanced pressure within the device. This pressure mitigation may result in a more consistent and controllable amount of fluid that is dispensed through the porous material 408 by preventing potential leakage that may have been caused by pressure differentials.



FIG. 5 illustrates air flow in the cartridge. There may be air inlets through which external air is received in the device. A wick 506 may include a heating element (e.g. coil) that vaporizes fluid that is absorbed onto the wick. The air flow may pass over or near the wick 506 and the heating element and then pass between the external tube 504 and bladder 502. The external tube 504 may be the external tube 304 and the bladder 502 may be the bladder 302 discussed above. In one embodiment the air path outside of the bladder 502 may be between the external tube 504 and a bladder support cylinder 508. The bladder support cylinder 508 may be used to support the bladder 502 and is sealed with a cap, while the external tube 504 results in an air path between the bladder support cylinder 508 and the external tube 504. As discussed above, the air flow may be generated by a user puffing (inhaling) on the device which results in a suction effect that pulls air through the air inlets.



FIG. 6 illustrates a sealed bladder in a cartridge for an aerosol delivery device. A cap or seal may be used to seal the bladder to prevent leakage, but to allow fluid flow upon device usage. As used herein, the term cap or seal may refer to multiple components include a cap 606 and a porous material 608 shown in FIG. 6. Those elements may be separate or may be combined as a singular cap/seal. The cap 606 may include a porous material 608 that allows from fluid flow from the fluid stored in the bladder 602. The bladder 602 is disposed within an external tube 604 for support. The bladder is sealed off to the external tube 604 with a silicone seal 610. The silicone seal 610 prevents fluid leakage, such that the fluid can only flow through the cap 606 and the porous material 608. Although described as silicone in this embodiment, the seal 610 may be formed of alternative materials that can fill the gap between the bladder connection to prevent fluid flow outside of the porous material 608. The silicone seal 610 is further illustrated in FIG. 7.



FIG. 7 illustrates one embodiment of a sealing mechanism for sealing a bladder in a cartridge. The silicone seal 610 may include ridges 702 for causing a compression or friction fit between the bladder 602 and the external tube 604. The compression fit causes the flexible bladder 602 to be pressed against the external tube 604 to prevent fluid leakage. In alternative embodiments, other seals may be utilized (other than a compression fit), including a screw mechanism, fastening mechanism, or gluing mechanism. The sealing that is used is designed to prevent fluid from the flexible bladder 602 from leaking on the outside portion of external tube 604. Rather, the fluid can only pass through the cap 606 and the porous material 608. Because the bladder 602 is flexible, it may need to be sealed in order to prevent this leakage. In one embodiment, the bladder 602 and the sealing mechanism is designed to be a one-time use or disposable cartridge that can be replaced.



FIG. 8 illustrates an embodiment of a cartridge with a modified air path. As discussed, the air flow around the bladder may include a gap between the bladder support cylinder and the external tube. FIG. 8 illustrates a modified air path 802 that includes additional spacing between the bladder support cylinder and the external tube. By shrinking a connector, there may be a lip 804 that can be used for other components (e.g. ultrasonic).



FIG. 9 illustrates an embodiment of an end of the cartridge in FIG. 8 with the modified air path. In particular, the modified air path 902 is shown from an end of the cartridge. The modified air path 902 may include an opening that allows for increased air flow. This modified air path 902 may be a tube that is external to the bladder and/or the external tube but within an outside housing of the aerosol device.



FIG. 10 illustrates a cartridge with a valve connection. The internal bladder may be held within an external container (e.g. external tube or cylindrical support). There may be a seal plate with an elastomeric valve that connects with a porous material (e.g. porous ceramic) for transporting the fluid during usage of the device. The valve may function to hold in the fluid unless it is activated and it allows liquid to seep into the porous ceramic which may contact a wick with a heating element for the vaporization process.



FIG. 11 illustrates a closed state of the elastomeric valve shown in FIG. 10. The elastomeric valve shown in FIG. 10 may be in a closed state when fully extended out from the bladder. The elastomeric valve is in a steady state 1102 awaiting displacement.



FIG. 12 illustrates an open state of the elastomeric valve shown in FIG. 10. The elastomeric valve shown in FIG. 10 may be in a closed state when pressed upwards towards the bladder. The elastomeric valve is in a depressed state 1202 in which the valve has been opened through displacement. In one embodiment, the user may apply the pressure that depresses the valve as shown in and described with respect to FIG. 13.



FIG. 13 illustrates another elastomeric valve. A user may physically press a portion 1302 (e.g. button) that presses into the valve. The pressure on the valve creates an open fluid path when the elastomeric portion is displaced. The elastomer in the relaxed position would seal the openings. The opening of the valve may be by displacement rather than pressure. In one embodiment, the sealed/closed state may be at manufacture and when the user adds the cartridge to their aerosol delivery device, the pressing of the cartridge into the device may cause the pressure needed to activate the valve and create a fluid path. This activation may be a one-time activation (i.e. when the cartridge is installed) or may be needed prior to each usage. For a disposable cartridge, the flexible bladder can remain in a sealed/closed state (with no leakage) until the cartridge is installed.



FIG. 14 illustrates a sealed state of the cartridge. In particular, the center plunger may activate the release or opening of the elastomeric valve. Further, FIG. 14 illustrates the flow path in a closed state. The cartridge may include the elastomeric valve shown and described with respect to FIGS. 10-13. Fluid flow may be completely blocked in a sealed state. Upon manufacture and prior to usage, the cartridge may be in the sealed state. Upon first usage, a user may depress the valve to trigger the open state shown in FIG. 15. FIG. 15 illustrates the flow path being open. The open state is created when the valve is depressed which opens a fluid flow path from the bladder through the ceramic material. The center plunger may activate the opening of the elastomeric valve. The open state may be referred to as an activated state.


In alternative embodiments, the elastomeric valve may be replaced with another component. For example, there may be other components, such as a membrane, that seals the bladder in a closed state, but upon activation provides fluid flow from the bladder. The activation may include an electronic activation (e.g. press a button) or a physical activation (e.g. user depresses end of the device to touch or displace the membrane).


In an alternative embodiment, the reservoir storing the aerosol precursor substance or the fluid intended for aerosol formation may have the form of at least one capsule or otherwise possess a capsule-type of format and configuration. That is, an aerosol precursor substance can be adapted to have a form so as to segregate, or otherwise create physical separation for, that aerosol precursor. A typical capsule-type configuration is provided by an inner region or core of aerosol precursor components, and an outer region or shell that acts as a wall or barrier structure to define the shape and volume of the inner region; as well as entrap, contain or encapsulate the aerosol precursor, thus providing storage or positioning of aerosol precursor in a manner so that the aerosol precursor is physically separated from other components of the aerosol delivery device into which that capsule is incorporated. If desired, a diluent material may be incorporated within the inner region of the capsule along with the aerosol precursor substance. Representative diluents are set forth in U.S. Pat. No. 8,695,609 to Dube et al.; and 2014/0053855 to Hartman et al., each of which are herein incorporated by reference. Preferably, each capsule is enclosed or sealed in such a way that the aerosol precursor substance does not leak from the capsule or may not be accessible from the capsule, prior to desired conditions of use.


Most preferably, a representative capsule is such that the outer shell or wall has sufficient resiliency and integrity to maintain encapsulation of the inner components during normal conditions or storage and handling; but can be broken to release the encapsulated inner components during conditions of normal use. For example, the capsule can be composed of a shell material so as to have a somewhat rigid exterior, or the capsule can have a somewhat flexible overall consistency. The outer wall or shell material of the capsule may be any of the following materials: proteins, polysaccharides, starches, waxes, fats, natural and synthetic polymers, and resins. Exemplary materials for use in the shell may include gelatin, acacia (gum arabic), polyvinyl acetate, potassium alginate, carob bean gum, potassium citrate, carrageenan, potassium polymetaphosphate, citric acid, potassium tripolyphosphate, dextrin, polyvinyl alcohol, povidone, dimethylpolysiloxane, dimethyl silicone, refined paraffin wax, ethylcellulose, bleached shellac, modified food starch, sodium alginate, guar gum, sodium carboxymethylcellulose, hydroxypropyl cellulose, sodium citrate, hydroxypropylmethylcellulose, sodium ferrocyanide, sodium polyphosphates, locust bean gum, methylcellulose, sodium trimetaphosphate, methyl ethyl cellulose, sodium tripolyphosphate, microcrystalline wax, tannic acid, petroleum wax, terpene resin, tragacanth, polyethylene, xanthan gum, and polyethylene glycol. If desired, the capsule can be over-coated with an outer barrier or seal on the outer region with a coating or moisture barrier. U.S. Pat. Pub. No. 2014/0053855 to Hartman et al. further describes capsule materials and is herein incorporated by reference.


The capsule is opened or activated to release the encapsulated contents. Typically, activation is performed by breaking, crushing, or melting of the capsule; and such activation most preferably is initialized by the user of the aerosol delivery device. For example, the user may either press a button to provide crushing of the capsule, or initiate an electronic signal that can further initiate chemical or physical action upon the capsule. Additionally, inhalation (i.e. when the flow sensor is triggered) may result in a physical crushing of the capsule or production of heat can act to degrade the physical integrity of the capsule wall, and hence release the inner, encapsulated contents of the capsule. The activation may be initialized by the user. For example, the user may either press a button, or inhalation (i.e. when the flow sensor is triggered) may activate the capsule. The initialization may include either a chemical reaction to break down the capsule, heating to break down the capsule, or some other electrical signal that breaks the capsule.


A capsule most preferably is positioned within the aerosol delivery device such that it can be broken when desired, and such that the contents of the capsule can be made available for aerosol production or for the enhancement of aerosol that is produced by the aerosol delivery device. As such, it is highly preferable, that contents released from the capsule are located in in the vicinity of the wicking components or resistance heating element of the aerosol delivery device (e.g., the capsules can be in contact with, or in a location sufficiently close to, the components of the aerosol delivery device that generate heat or exhibit increased temperature during conditions of use. Thus, the contents of the capsule, which include aerosol precursor components, can be subjected to heat generated for aerosol formation, and hence can be vaporized for aerosol formation.


Numerous ways of handling breakable capsules and incorporating those breakable capsules into components of smoking articles and vapor delivery systems have been proposed. For example, various types of capsules suitable for use in smoking articles, smoking article components that incorporate breakable capsules, and equipment and techniques associated with manufacturing those smoking article components, are proposed in U.S. Pat. No. 6,631,722 to MacAdam et al.; U.S. Pat. No. 7,479,098 to Thomas et al.; U.S. Pat. No. 7,833,146 to Deal; U.S. Pat. No. 7,984,719 to Dube et al.; U.S. Pat. No. 7,972,254 to Stokes et al.; U.S. Pat. No. 8,186,359 to Ademe et al.; U.S. Pat. No. 8,262,550 to Barnes et al.; U.S. Pat. No. 8,308,623 to Nelson et al.; U.S. Pat. No. 8,353,810 to Garthaffner et al.; U.S. Pat. No. 8,381,947 to Garthaffner et al.; U.S. Pat. No. 8,459,272 to Karles et al.; U.S. Pat. No. 8,739,802 to Fagg; U.S. Pat. No. 8,905,243 to Dixon et al. and U.S. Pat. No. 9,055,768 to Henley et al.; US Pat. App. Pub. Nos. 2010/0184576 to Prestia et al.; 2011/0053745 to They et al.; 2011/0271968 to Carpenter et al.; to Henley et al. and 2013/0085052 to Novak III, et al.; and U.S. patent application Ser. No. 14/835,962, filed Aug. 26, 2015 to Ademe; which are incorporated herein by reference. Additionally, representative cigarette products that possess filter elements incorporating breakable capsules have been marketed throughout the world under the brandnames such as “Marlboro W-Burst 5,” “Kent iSwitch,” “Kool Boost,” “Camel Lights with Menthol Boost,” “Camel Crush,” “Camel Silver Menthol,” “Camel Filters Menthol,” and “Camel Crush Bold.” Furthermore, representative types of vapor delivery systems that incorporate breakable capsules have been proposed in U.S. Pat. Pub. Nos. 2014/0261486 to Potter and 2015/0059780 to Davis; and U.S. patent application Ser. No. 14/282,768 to Sears et al., filed May 20, 2014; which are incorporated herein by reference.


Exemplary types of capsules, capsule ingredients, capsule configurations and formats, capsule sizes, capsule properties and capsule preparation techniques are set forth in U.S. Pat. No. 5,223,185 to Takei et al.; U.S. Pat. No. 5,387,093 to Takei; U.S. Pat. No. 5,882,680 to Suzuki et al.; U.S. Pat. No. 6,719,933 to Nakamura et al.; U.S. Pat. No. 7,754,239 to Mane; U.S. Pat. No. 6,949,256 to Fonkwe et al.; U.S. Pat. No. 7,984,719 to Dube et al.; U.S. Pat. No. 8,470,215 to Zhang and U.S. Pat. No. 8,695,609 to Dube et. al.; U.S. Pat. App. Pub. Nos. 2004/0224020 to Schoenhard; 2005/0196437 to Bednarz et al.; 2005/0249676 to Scott et al. and 2014/0053855 to Hartmann et al.; and PCT WO 03/009711 to Kim and PCT WO 2014/170947 to Iwatani; which are incorporated herein by reference. Additionally, examples of representative types of capsules and capsule components have been commercially available as “Momints” by Yosha! Enterprises, Inc. and “Ice Breakers Liquid Ice” from The Hershey Company; and representative types of capsules and capsule components have be incorporated into chewing gum, such as the type of gum marketed under the tradename “Cinnaburst” by Cadbury Adams USA.


Representative encapsulated components can vary. One example of an encapsulated formulation includes propylene glycol, glycerin, nicotine, organic acids and flavoring agents. An example of a suitable capsule is composed of an outer shell that possesses chemical and physical properties sufficient to provide a sealed container of good integrity for the encapsulated components. For example, such a shell can be provided using components comparable to use used to create those capsules used for the production of capsules used in filter elements of cigarettes marketed under the brand name “Camel Crush” by R. J. Reynolds Tobacco Company.



FIG. 16 illustrates a cartridge 1600 for an aerosol delivery device including one or capsules. FIG. 16 is similar to the embodiment shown in FIG. 2, except the fluid container 202 with the flexible bladder 206 is replaced with one or more capsules 1603 in a container 1602. Although eight capsules 1603 are illustrated in FIG. 16, there may be just a single capsule for providing the aerosol precursor substance or there may be many more capsules with that substance. In an alternative embodiment, the aerosol precursor substance may be located in the container 1602 (e.g. in a flexible bladder) while capsules may be used for flavoring of that substance or to provide ingredients other than flavoring agents, such as nicotine. In particular, the capsule may act as a supplement to the aerosol precursor substance which may be present in a separate fluid container from the capsule. In an alternative embodiment, the capsule may be in a fluid container that includes the aerosol precursor substance and they are mixed upon activation of the capsule. The fluid container may be a flexible bladder as discussed above.


The overall shape of a capsule can vary. Typically, representative capsules are generally spherical in shape. However, the outer shell of the capsule can be adapted to have shapes that can be characterized as being, for example, generally cylindrical, bean-shaped, ovaloid or elongated in nature. FIG. 17 illustrates alternative embodiments of capsules. The capsules 1603 in FIG. 16 are merely exemplary and may be in different shapes. FIG. 17 illustrates capsules of different shapes. In addition, the capsules may be different sizes. There may be a single large capsule or many smaller microcapsules. FIG. 17 illustrates a tubular capsule 1702, a square capsule 1704, an oval or egg shaped capsule 1706, or a round/circular/spherical capsule 1708. The shapes shown in FIG. 17 are merely exemplary. Activation of those capsules may be similar to or the same as the capsules 1603 in FIG. 16.


The size of the capsule can vary. For example, a relatively large sized capsule that employed to replace the collapsible bladder, the capsule can have an overall size that in comparable to that of the previously described collapsible bladder. The capsule also can be relatively small; and as such, for example, a plurality of microcapsules (e.g., about 50 to about 200 of such small capsules) can be incorporated within each aerosol delivery device. Additionally, spherical capsules having diameters of about 0.5 mm to about 3 mm can be incorporated within each aerosol delivery device; and in such a circumstance, an exemplary aerosol delivery device can incorporate 1 such capsule to about 10 capsules.



FIG. 18 illustrates an alternative cartridge 1800 for an aerosol delivery device including one or capsules disposed adjacent the heating element. In particular, the cartridge 1800 illustrates that the one or more capsules 1803 may be disposed or located adjacent the heating element 1814. The heating element 1814 may include a wick and heater. The wick receives the aerosol precursor substance or other fluid from activation of the capsules 1803. Based on the proximity with the capsules 1803 the heating element 1814 may result in the melting of the capsules 1803 or a portion of the capsules 1803. In other words, activation of the capsules 1803 may be through melting from the heating element 1814. A flow-tube 1812 or terminal support may be support the heating element 1814 so that the capsules 1803 are contained and located adjacent the heating element 1814.



FIG. 19 illustrates a breaking mechanism for the capsules. In particular, there may be a moveable element 1902 (similar to the embodiment for opening the elastomeric valve discussed above) which breaks or activates the capsules 1903. As described in the embodiment with an elastomeric valve which is activated for generating a fluid flow path, the capsules 1903 may be activated by being broken or crushed (e.g. microcapsules) by the breaking mechanism. The capsules 1903 may be broken by a force or stress applied by a user with the moveable element 1902 upon usage of the device. The force may include compressive force applied to the exterior or shell (i.e., a mechanical force such as squeezing or twisting) to rupture and release the substance in the capsules 1903.


In an alternative embodiment, the capsule(s) 1903 may be located adjacent the moveable element 1902. The direct force from the moveable element 1902 may cause breakage of the capsule(s) 1903. In an embodiment similar to that shown in FIG. 18, the capsule(s) 1903 may be adjacent the heating element.


The foregoing description of use of the article(s) can be applied to the various example implementations described herein through minor modifications, which can be apparent to the person of skill in the art in light of the further disclosure provided herein. The above description of use, however, is not intended to limit the use of the article but is provided to comply with all necessary requirements of disclosure of the present disclosure. Any of the elements shown in the article(s) illustrated in the Figures or as otherwise described above may be included in an aerosol delivery device according to the present disclosure.


Many modifications and other implementations of the disclosure set forth herein will come to mind to one skilled in the art to which these disclosure pertain having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the disclosure are not to be limited to the specific implementations disclosed and that modifications and other implementations are intended to be included within the scope of the appended claims. Moreover, although the foregoing descriptions and the associated drawings describe example implementations in the context of certain example combinations of elements and/or functions, it should be appreciated that different combinations of elements and/or functions may be provided by alternative implementations without departing from the scope of the appended claims. In this regard, for example, different combinations of elements and/or functions than those explicitly described above are also contemplated as may be set forth in some of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.


The illustrations of the embodiments described herein are intended to provide a general understanding of the structure of the various embodiments. The illustrations are not intended to serve as a complete description of all of the elements and features of apparatus and systems that utilize the structures or methods described herein. Many other embodiments may be apparent to those of skill in the art upon reviewing the disclosure. Other embodiments may be utilized and derived from the disclosure, such that structural and logical substitutions and changes may be made without departing from the scope of the disclosure. Additionally, the illustrations are merely representational and may not be drawn to scale. Certain proportions within the illustrations may be exaggerated, while other proportions may be minimized. Accordingly, the disclosure and the figures are to be regarded as illustrative rather than restrictive.


It is intended that the foregoing detailed description be understood as an illustration of selected forms that the invention can take and not as a definition of the invention. It is only the following claims, including all equivalents that are intended to define the scope of the claimed invention. Finally, it should be noted that any aspect of any of the preferred embodiments described herein can be used alone or in combination with one another.

Claims
  • 1. An electronic cigarette comprising: a mouthpiece configured to receive air with vapor;a soft fluid bladder storing a fluid and configured to prevent excess air in the bladder by collapsing as the fluid is removed;a member configured to support the soft fluid bladder;a porous material coupled with the soft fluid bladder and configured to transfer a portion of the fluid; andan atomizer configured to receive the portion of the fluid transferred from the porous material, wherein the atomizer is configured to generate the vapor by heating the transferred fluid.
  • 2. The electronic cigarette of claim 1 wherein the porous material comprises a wick configured to receive the fluid.
  • 3. The electronic cigarette of claim 2 wherein the atomizer comprises a heating element configured to heat the fluid from the wick.
  • 4. The electronic cigarette of claim 3 wherein the heating element comprises a heating wire wrapped around the wick.
  • 5. The electronic cigarette of claim 3 further comprising a battery configured to provide power to the heating element.
  • 6. The electronic cigarette of claim 1 wherein the soft fluid bladder comprises a latex or thin plastic and the porous material cap comprises a porous ceramic material.
  • 7. The electronic cigarette of claim 1 wherein the porous material comprises a porous ceramic material.
  • 8. The electronic cigarette of claim 1 wherein the porous material comprises a cap configured for sealing the soft fluid bladder.
  • 9. The electronic cigarette of claim 8 wherein the cap seals the soft fluid bladder by creating a compression fit of the soft fluid bladder.
  • 10. The electronic cigarette of claim 1 wherein the member comprises a cylindrical tube configured to hold the soft fluid bladder.
  • 11. An aerosol delivery device comprising: a container storing an aerosol precursor substance;a moveable wall enclosed by the container that is configured to move relative to the container to release the aerosol precursor substance; anda vaporizer configured to receive the aerosol precursor substance after the moveable wall causes the releasing, wherein the vaporizer generates an aerosol by vaporizing the aerosol precursor substance.
  • 12. The aerosol delivery device of claim 11 wherein the movement relative the container comprises the moveable wall breaking the one or more capsules to release the aerosol precursor substance.
  • 13. The aerosol delivery device of claim 12 wherein the moveable wall comprises the heating element that is configured to melt at least a portion of the one or more capsules.
  • 14. The aerosol delivery device of claim 13 wherein the movement relative the container comprises the moveable mechanism breaking the one or more capsules to release the aerosol precursor substance.
  • 15. The aerosol delivery device of claim 13 wherein the moveable mechanism comprises the heating element that is configured to melt at least a portion of the one or more capsules.
  • 16. The aerosol delivery device of claim 13 wherein the capsules are stored and released near the heating element and the wick.
  • 17. A vaporization device comprising: a battery portion; anda cartridge configured to receive power from the battery portion and to store a fluid, the cartridge comprising: a flexible bladder configured to hold the fluid that equalizes a pressure inside the flexible bladder to control leakage caused by pressure changes, wherein the equalization of pressure is due to a shape of the flexible bladder collapsing as the fluid is removed;a porous material coupled with the flexible bladder that is configured to transfer at least a portion of the fluid from the flexible bladder; anda heating element configured to generate vapor from the fluid.
  • 18. The vaporization device of claim 17, wherein the cartridge further comprises a wick configured to receive the at least a portion of the fluid from the porous material, wherein the heating element comprises a wire wrapped around the wick.
  • 19. The vaporization device of claim 18, wherein the porous material comprises a porous ceramic.
  • 20. The vaporization device of claim 17, wherein the cartridge further comprises a tube configured to support the flexible bladder and the porous material comprises a cap that seals the flexible bladder.
PRIORITY

This application claims priority as a Continuation to U.S. application Ser. No. 14/854,968, filed on Sep. 15, 2015, entitled “RESERVOIR FOR AEROSOL DELIVERY DEVICES,” now U.S. Pat. No. 10,034,494, the entire disclosure of which is hereby incorporated by reference.

US Referenced Citations (418)
Number Name Date Kind
438310 Edison Oct 1890 A
705919 Gill Jul 1902 A
780087 Burt Jan 1905 A
1016844 Moonelis Feb 1912 A
1084304 Vaughn Jan 1914 A
1147416 MacDonald Jul 1915 A
1347631 Jean Jul 1920 A
1446087 Griffin Feb 1923 A
1514682 Wilson Nov 1924 A
1517584 Reece Dec 1924 A
1771366 Wyss et al. Jul 1930 A
1879128 Despe Sep 1932 A
2032695 Gimera Mar 1936 A
2057353 Whittemore, Jr. Oct 1936 A
2086192 Schumaker Jul 1937 A
2104266 McCormick Jan 1938 A
2140516 Cowan Dec 1938 A
2461664 Smith Feb 1949 A
2472282 Burchett Jun 1949 A
2545851 Kardos Mar 1951 A
2959664 Fenn Nov 1960 A
3060429 Winston Oct 1962 A
3200819 Gilbery Aug 1965 A
3203025 Schreur Aug 1965 A
3234357 Seuthe Feb 1966 A
3258015 Ellis et al. Jun 1966 A
3281637 Hultquist Oct 1966 A
3292635 Kolodny Dec 1966 A
3356094 Ellis et al. Dec 1967 A
3385303 Hind May 1968 A
3428053 Schoenbaum Feb 1969 A
3431393 Katsuda Mar 1969 A
3479561 Janning Nov 1969 A
3486508 Sipos Dec 1969 A
3502588 Winberg Mar 1970 A
3516417 Moses Jun 1970 A
3614056 Thornton Oct 1971 A
3651240 Kirkpatrick Mar 1972 A
3685521 Dock Aug 1972 A
3685522 Kleinhans Aug 1972 A
3738374 Bennett Jun 1973 A
3747120 Stemme Jul 1973 A
3766000 Gibson Oct 1973 A
3844294 Webster Oct 1974 A
3860012 Selke Jan 1975 A
3878850 Gibson et al. Apr 1975 A
3931824 Miano et al. Jan 1976 A
3933643 Colvin Jan 1976 A
3934117 Schladitz Jan 1976 A
3943941 Boyd et al. Mar 1976 A
4016878 Castel et al. Apr 1977 A
4044777 Boyd et al. Aug 1977 A
4079742 Rainer et al. Jan 1978 A
4190046 Virag Feb 1980 A
4207457 Haglund Jun 1980 A
4219031 Rainer et al. Aug 1980 A
4219032 Tabatznik Aug 1980 A
4233993 Miano et al. Nov 1980 A
4270552 Jenkins Jun 1981 A
4284089 Ray Aug 1981 A
4286604 Ehretsmann et al. Sep 1981 A
4303083 Burruss, Jr. Dec 1981 A
4326544 Hardwick et al. Apr 1982 A
4340072 Bolt et al. Jul 1982 A
4347855 Lanzillotti et al. Sep 1982 A
4391285 Burnett et al. Jul 1983 A
4506682 Muller Mar 1985 A
4531178 Uke Jul 1985 A
4589428 Keritsis May 1986 A
4629665 Matsuo Dec 1986 A
4635651 Jacobs Jan 1987 A
4637407 Bonanno Jan 1987 A
4676237 Wood Jun 1987 A
4700727 Torigian Oct 1987 A
4714082 Banerjee et al. Dec 1987 A
4735217 Gerth et al. Apr 1988 A
4756318 Clearman et al. Jul 1988 A
4771295 Baker Sep 1988 A
4771795 White et al. Sep 1988 A
4771796 Myer Sep 1988 A
4793365 Sensabaugh, Jr. et al. Dec 1988 A
4797692 Ims Jan 1989 A
4800903 Ray et al. Jan 1989 A
4807809 Pryor et al. Feb 1989 A
4819665 Roberts et al. Apr 1989 A
4823817 Luke Apr 1989 A
4836225 Sudoh Jun 1989 A
4848374 Chard et al. Jul 1989 A
4874000 Tamol et al. Oct 1989 A
4878506 Pinck Nov 1989 A
4892109 Stubel Jan 1990 A
4893639 White Jan 1990 A
4907606 Lilja et al. Mar 1990 A
4917121 Riehl et al. Apr 1990 A
4917128 Clearman et al. Apr 1990 A
4920990 Lawrence May 1990 A
4922901 Brooks et al. May 1990 A
4924886 Litzinger May 1990 A
4941486 Dube Jul 1990 A
4945448 Bremenour Jul 1990 A
4945929 Egilmex Aug 1990 A
4945931 Gori Aug 1990 A
4947874 Brooks et al. Aug 1990 A
4947875 Brooks et al. Aug 1990 A
4961438 Korte Oct 1990 A
4966171 Serrano et al. Oct 1990 A
4968263 Silbernagel Nov 1990 A
4969476 Bale et al. Nov 1990 A
4972855 Kuriyama Nov 1990 A
4977908 Luke Dec 1990 A
4981522 Nichols et al. Jan 1991 A
4986286 Roberts et al. Jan 1991 A
4990939 Sekiya Feb 1991 A
4991606 Serrano et al. Feb 1991 A
5005593 Fagg Apr 1991 A
5019122 Clearman et al. May 1991 A
5020548 Farrier et al. Jun 1991 A
5025814 Raker Jun 1991 A
5033483 Clearman et al. Jul 1991 A
5040551 Schlatter et al. Aug 1991 A
5042510 Curtiss et al. Aug 1991 A
5046514 Bolt Sep 1991 A
5050621 Creighton et al. Sep 1991 A
5060667 Strubel Oct 1991 A
5060671 Counts et al. Oct 1991 A
5060676 Hearn et al. Oct 1991 A
5065776 Lawson et al. Nov 1991 A
5072744 Luke et al. Dec 1991 A
5074321 Gentry et al. Dec 1991 A
5076296 Nystrom et al. Dec 1991 A
5076297 Farrier et al. Dec 1991 A
5092353 Montoya et al. Mar 1992 A
5093894 Deevi et al. Mar 1992 A
5099861 Clearman et al. Mar 1992 A
5101839 Jakob et al. Apr 1992 A
5105835 Drewett et al. Apr 1992 A
5105836 Gentry et al. Apr 1992 A
5105837 Barnes et al. Apr 1992 A
5105838 White et al. Apr 1992 A
5115820 Hauser et al. May 1992 A
5124200 Mallonee Jun 1992 A
5129409 White Jul 1992 A
5144962 Counts et al. Sep 1992 A
5146934 Deevi et al. Sep 1992 A
5148821 Best et al. Sep 1992 A
5159940 Hayward et al. Nov 1992 A
5159942 Brinkley et al. Nov 1992 A
5177424 Connors Jan 1993 A
5178167 Riggs et al. Jan 1993 A
5183062 Clearman et al. Feb 1993 A
5203335 Clearman et al. Apr 1993 A
5211684 Shannon et al. May 1993 A
5224265 Dux Jul 1993 A
5224498 Deevi et al. Jul 1993 A
5240014 Deevi et al. Aug 1993 A
5240016 Nichols et al. Aug 1993 A
5249586 Morgan et al. Oct 1993 A
5255674 Oftedal et al. Oct 1993 A
5261424 Sprinkle et al. Nov 1993 A
5266746 Nishihara Nov 1993 A
5271419 Arzonico et al. Dec 1993 A
5282798 Banerjee et al. Feb 1994 A
5293883 Edwards Mar 1994 A
5322075 Deevi et al. Jun 1994 A
5327915 Porenski Jul 1994 A
5327917 Lekwauwa et al. Jul 1994 A
5345955 Clearman et al. Sep 1994 A
5353813 Deevi et al. Oct 1994 A
5357984 Farrier et al. Oct 1994 A
5360023 Blakely et al. Nov 1994 A
5369723 Counts et al. Nov 1994 A
5372148 McCafferty Dec 1994 A
5388574 Ingebrethsen Feb 1995 A
5388594 Counts et al. Feb 1995 A
5396911 Casey, III et al. Mar 1995 A
5408574 Deevi et al. Apr 1995 A
5468936 Deevi et al. Nov 1995 A
5497791 Bowen Mar 1996 A
5498850 Das Mar 1996 A
5505214 Collins et al. Apr 1996 A
5515842 Ramsayer et al. May 1996 A
5530225 Hajaligol Jun 1996 A
5533530 Young et al. Jul 1996 A
5551451 Riggs et al. Sep 1996 A
5564442 MacDonald et al. Oct 1996 A
5588446 Clearman et al. Dec 1996 A
5593792 Farrier et al. Jan 1997 A
5595577 Bensalem et al. Jan 1997 A
5598868 Jakob et al. Feb 1997 A
5646666 Cowger Jul 1997 A
5649554 Sprinkle et al. Jul 1997 A
5665262 Hajaligol et al. Sep 1997 A
5666977 Higgins Sep 1997 A
5666978 Counts et al. Sep 1997 A
5687746 Rose et al. Nov 1997 A
5692525 Counts Dec 1997 A
5703633 Gehrer Dec 1997 A
5715844 Young et al. Feb 1998 A
5726421 Fleischhauer et al. Mar 1998 A
5727571 Meiring et al. Mar 1998 A
5732685 Nakamura Mar 1998 A
5743251 Howell et al. Apr 1998 A
5745985 Ghosh May 1998 A
5778899 Sato et al. Jul 1998 A
5799663 Gross et al. Sep 1998 A
5819751 Barnes et al. Oct 1998 A
5819756 Mielordt Oct 1998 A
5829453 White et al. Nov 1998 A
5865185 Collins et al. Feb 1999 A
5865186 Volsey, II Feb 1999 A
5878752 Adams et al. Mar 1999 A
5880439 Deevi et al. Mar 1999 A
5894841 Voges Apr 1999 A
5915387 Baggett, Jr. et al. Jun 1999 A
5934289 Watkins et al. Aug 1999 A
5944025 Cook Aug 1999 A
5954979 Counts et al. Sep 1999 A
5967148 Hasrris et al. Oct 1999 A
5996589 St. Charles Dec 1999 A
6033623 Deevi et al. Mar 2000 A
6040560 Fleischhauer et al. Mar 2000 A
6053176 Adams et al. Apr 2000 A
6062213 Fuisz May 2000 A
6089857 Matsuura et al. Jul 2000 A
6095152 Beven et al. Aug 2000 A
6095153 Kessler et al. Aug 2000 A
6102036 Slutsky Aug 2000 A
6125853 Susa et al. Oct 2000 A
6146934 Gardner et al. Nov 2000 A
6155268 Takeuchi Dec 2000 A
6164287 White Dec 2000 A
6182670 White et al. Feb 2001 B1
6196218 Voges Mar 2001 B1
6196219 Hess et al. Mar 2001 B1
6217315 Mifune Apr 2001 B1
6232784 Dulasky May 2001 B1
6234167 Cox et al. May 2001 B1
6285017 Brickell Sep 2001 B1
6289898 Fournier et al. Sep 2001 B1
6311561 Bang Nov 2001 B1
6322268 Kaufmann Nov 2001 B1
6397852 McAdam Jun 2002 B1
6408856 McAdam Jun 2002 B1
6476151 Araki Nov 2002 B1
6501052 Cox Dec 2002 B2
6516796 Cox et al. Feb 2003 B1
6532965 Abhulimen et al. Feb 2003 B1
6537186 Veluz Mar 2003 B1
6578584 Beven et al. Jun 2003 B1
6591841 White et al. Jul 2003 B1
6598607 Adiga et al. Jul 2003 B2
6601776 Oljaca et al. Aug 2003 B1
6615840 Fournier et al. Sep 2003 B1
6620659 Emmma et al. Sep 2003 B2
6688313 Wrenn et al. Feb 2004 B2
6690121 Weindorf Feb 2004 B1
6719443 Gutstein Apr 2004 B2
6722763 Hsu Apr 2004 B1
6730832 Dominguez et al. May 2004 B1
6772756 Shayan Aug 2004 B2
6803545 Blake et al. Oct 2004 B2
6823873 Nichols et al. Nov 2004 B2
6854461 Nichols Feb 2005 B2
6854470 Pu Feb 2005 B1
6885814 Saito Apr 2005 B2
6938986 Macler Sep 2005 B2
6994096 Rostami et al. Feb 2006 B2
7117867 Cox et al. Oct 2006 B2
7284424 Kanke Oct 2007 B2
7293565 Griffin et al. Nov 2007 B2
7337782 Thompson Mar 2008 B2
7445007 Balch Nov 2008 B2
7513253 Kobayashi et al. Apr 2009 B2
7726320 Robinson et al. Jun 2010 B2
7775459 Martins, III et al. Aug 2010 B2
7832410 Hon Nov 2010 B2
7845359 Montaser Dec 2010 B2
7896006 Hamano et al. Mar 2011 B2
7972254 Stokes et al. Jul 2011 B2
7997280 Rosenthal Aug 2011 B2
8042550 Urtsev et al. Oct 2011 B2
8079371 Robinson et al. Dec 2011 B2
8127772 Montaser Feb 2012 B2
8314591 Terry et al. Nov 2012 B2
8365742 Hon Feb 2013 B2
8402976 Fernando et al. Mar 2013 B2
8459271 Inagaki Jun 2013 B2
8470215 Zhang Jun 2013 B2
8499766 Newton Aug 2013 B1
8528569 Newton Sep 2013 B1
8550069 Alelov Oct 2013 B2
8695609 Dube et al. Apr 2014 B2
8739802 Fagg Jun 2014 B2
8820331 Hartmann et al. Sep 2014 B2
8881737 Collett et al. Nov 2014 B2
8899228 Robison et al. Dec 2014 B2
9220302 DePiano Dec 2015 B2
9532597 Tucker et al. Jan 2017 B2
9597466 Henry, Jr. Mar 2017 B2
9609893 Novak, III Apr 2017 B2
9717276 Brammer Aug 2017 B2
20010026788 Piskorz Oct 2001 A1
20020146242 Vieira Oct 2002 A1
20030011579 Gong Jan 2003 A1
20030033055 McRae Feb 2003 A1
20030108342 Sherwood Jun 2003 A1
20030131859 Li et al. Jul 2003 A1
20030189826 Yoon Oct 2003 A1
20030226837 Blake et al. Dec 2003 A1
20040020508 Earl Feb 2004 A1
20040118401 Smith et al. Jun 2004 A1
20040129280 Woodson et al. Jul 2004 A1
20040149282 Hickle Aug 2004 A1
20040173229 Crooks et al. Sep 2004 A1
20040198127 Yamamoto et al. Oct 2004 A1
20040200488 Felter et al. Oct 2004 A1
20040226568 Takeuchi et al. Nov 2004 A1
20040234916 Hale Nov 2004 A1
20040261802 Griffin Dec 2004 A1
20050016549 Banerjee et al. Jan 2005 A1
20050016550 Katase Jan 2005 A1
20050066986 Nestor et al. Mar 2005 A1
20050115243 Adle Jun 2005 A1
20060016453 Kim Jan 2006 A1
20060093977 Pellizzari May 2006 A1
20060185687 Hearn et al. Aug 2006 A1
20060196518 Hon Sep 2006 A1
20070030306 Okamura Feb 2007 A1
20070062549 Holton, Jr. et al. Feb 2007 A1
20070074734 Braunshteyn et al. Apr 2007 A1
20070102013 Adams et al. May 2007 A1
20070215167 Crooks et al. Sep 2007 A1
20070267031 Hon Nov 2007 A1
20080085103 Beland et al. Apr 2008 A1
20080092912 Robinson et al. Apr 2008 A1
20080257367 Paterno et al. Oct 2008 A1
20080276947 Martzel Nov 2008 A1
20080302374 Wenger et al. Dec 2008 A1
20090095311 Han Apr 2009 A1
20090095312 Herbrich et al. Apr 2009 A1
20090126745 Hon May 2009 A1
20090188490 Han Jul 2009 A1
20090230117 Fernando et al. Sep 2009 A1
20090255534 Paterno Oct 2009 A1
20090272379 Thorens et al. Nov 2009 A1
20090283103 Nielsen et al. Nov 2009 A1
20090320864 Fernando et al. Dec 2009 A1
20100043809 Magnon Feb 2010 A1
20100083959 Siller Apr 2010 A1
20100200006 Robinson et al. Aug 2010 A1
20100229881 Hearn Sep 2010 A1
20100242974 Pan Sep 2010 A1
20100307518 Wang Dec 2010 A1
20100313901 Fernando et al. Dec 2010 A1
20110005535 Xiu Jan 2011 A1
20110011286 Fang Jan 2011 A1
20110036363 Urtsev et al. Feb 2011 A1
20110036365 Chong et al. Feb 2011 A1
20010094523 Thorens et al. Apr 2011
20110120482 Brenneise May 2011 A1
20110126848 Zuber et al. Jun 2011 A1
20110155153 Thorens et al. Jun 2011 A1
20110155718 Greim et al. Jun 2011 A1
20110168194 Hon Jul 2011 A1
20110232654 Mass Sep 2011 A1
20110265806 Alacon et al. Nov 2011 A1
20110266236 Clark et al. Nov 2011 A1
20110309157 Yang et al. Dec 2011 A1
20120042885 Stone et al. Feb 2012 A1
20120060853 Robinson et al. Mar 2012 A1
20120111347 Hon May 2012 A1
20120132643 Choi et al. May 2012 A1
20120227752 Alelov Sep 2012 A1
20120231464 Yu et al. Sep 2012 A1
20120255567 Rose et al. Oct 2012 A1
20120260927 Liu Oct 2012 A1
20120279512 Hon Nov 2012 A1
20120285475 Liu Nov 2012 A1
20120318882 Abelhasera Dec 2012 A1
20130037031 Worm et al. Feb 2013 A1
20130056013 Terry et al. Mar 2013 A1
20130081625 Rustad et al. Apr 2013 A1
20130081642 Safari Apr 2013 A1
20130085052 Novak, III et al. Apr 2013 A1
20130192619 Tucker Aug 2013 A1
20130255702 Griffith, Jr. et al. Oct 2013 A1
20130306074 Flick Nov 2013 A1
20130319439 Gorelick et al. Dec 2013 A1
20130340750 Thorens et al. Dec 2013 A1
20130340775 Juster et al. Dec 2013 A1
20140000638 Sebastian et al. Jan 2014 A1
20140026887 Portney Jan 2014 A1
20140060554 Collett et al. Mar 2014 A1
20140060555 Chang et al. Mar 2014 A1
20140096781 Sears et al. Apr 2014 A1
20140096782 Ampolini Apr 2014 A1
20140109921 Chen Apr 2014 A1
20140157583 Ward et al. Jun 2014 A1
20140209105 Sears et al. Jul 2014 A1
20140253144 Novak et al. Sep 2014 A1
20140261408 DePiano et al. Sep 2014 A1
20140261486 Potter et al. Sep 2014 A1
20140261487 Chapman et al. Sep 2014 A1
20140261495 Novak, III Sep 2014 A1
20140270727 Ampolini et al. Sep 2014 A1
20140270729 DePiano et al. Sep 2014 A1
20140270730 DePiano et al. Sep 2014 A1
20140345631 Bowen et al. Nov 2014 A1
20150059780 Davis et al. Mar 2015 A1
20150117841 Brammer et al. Apr 2015 A1
20150136158 Stevens et al. May 2015 A1
20150201674 Dooly et al. Jul 2015 A1
20150216232 Bless et al. Aug 2015 A1
20150230521 Talon Aug 2015 A1
20150245659 DePiano Sep 2015 A1
20150351456 Johnson Dec 2015 A1
20170071249 Ampolini Mar 2017 A1
20170105448 Scarpulla Apr 2017 A1
Foreign Referenced Citations (42)
Number Date Country
276250 Jul 1965 AU
2293957 Oct 1998 CN
12333436 Nov 1999 CN
1541577 Nov 2004 CN
2719043 Aug 2005 CN
201018927 Feb 2008 CN
201067079 Jun 2008 CN
201085044 Jul 2008 CN
104095291 Oct 2014 CN
2704218 Aug 1978 DE
102006004484 Aug 2007 DE
0 358 114 Mar 1990 EP
0 430 559 Jun 1991 EP
0 430 566 Jun 1991 EP
0 501 419 Sep 1992 EP
0 503 767 Sep 1992 EP
0 845 220 Jun 1998 EP
0 295 122 Dec 1998 EP
1 584 910 Oct 2005 EP
1 618 803 Jan 2006 EP
1911 25575 Mar 1912 GB
588117 May 1947 GB
755475 Aug 1956 GB
1431045 Apr 1976 GB
2070409 Sep 1981 GB
H9-326299 Dec 1977 JP
2000041654 Feb 2000 JP
P2001-291598 Oct 2001 JP
2002-0067473 Aug 2002 KR
WO 8602528 May 1986 WO
WO 9748293 Dec 1997 WO
WO 9816125 Apr 1998 WO
WO 0028843 May 2000 WO
WO 0237990 May 2002 WO
WO 2004080216 Sep 2004 WO
WO 2004095955 Nov 2004 WO
WO 2005099494 Oct 2005 WO
WO 2007078273 Jul 2007 WO
WO 2007131449 Nov 2007 WO
WO 2007131450 Nov 2007 WO
WO 2015077645 May 2015 WO
WO-2015077645 May 2015 WO
Non-Patent Literature Citations (15)
Entry
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Mar. 20, 2018 for PCT Application No. PCT/US2016/051638 (9 pp.).
International Search Report and Written Opinion of the International Searching Authority dated Feb. 9, 2017 for PCT Application No. PCT/US2016/051638 (14 pp.).
Andrus et al., “Nicotine Microaerosol Inhaler”, Can Respir Journal, vol. 6, No. 6, 1999, pp. 509-512.
Avallone et al., “Mark's Standard Handbook for Mechanical Engineers,” published 1978, p. 15-6 (3 pg.).
Cengel et al., “Thermodynamics: An Engineering Approach,” (5th ed. 2006) (excerpts) (“Thermodynamics”), 9 pgs.
Dally, James W., “Packaging of Electronic Systems: A Mechanical Engineering Approach” (excerpts) (1990), 18 pgs.
Fuchs, N.A. “The Mechanics of Aerosols” (1989), 22 pgs.
International Search Report and Written Opinion of the International Searching Authority dated Feb. 9, 2017 for PCT Application No. PCT/US2016/051638 (15 pp.).
Messier, Jr., Robert W., “Joining of Materials and Structures,” Elsevier Butterworth-Heinemann 2004—Excerpt, 4 pgs.
Mosdesign Semiconductor Corp. Datasheet for M1600 LED Drivers (“Mosdesign M1600 Datasheet”), 1 pg.
MPL 502 Series Specifications, Micro Pneumatic Logic, Inc., (Mar. 11, 2006), http://www.pressureswitch.com/PDFs/0502STANDARDA.pdf [https://web.archive.org/web/20060311132848/http://www.pressureswitch.com/PDFs/0502STANDARDA.pdf], 17 pgs.
MPL Pressure Switch Solutions, Micro Pneumatic Logic, Inc., (Product Brochure) (Mar. 11, 2006), http://www.pressureswitch.com/PDFs/2000_MPLBrochure.pdf [https://web.archive.org/web/20060311132419/http://www.pressureswitch.com/PDFs/2000_MPLBrochure.pdf]. 2 pgs.
Rohsenow, Warren M., “Heat, Mass, and Momentum Transfer”, copyright 1961 Prentice-Hall, 3 pgs.
Speck, James A., “Mechanical Fastening, Joining, and Assembly,” Marcel Dekker, Inc. 1997, 4 pgs.
Thermal Ink—Jet Print Cartridge Designer's Guide (2nd Edition Hewlett Packard) (“Jet Print Cartridge Designers Guide”), 12 pgs.
Related Publications (1)
Number Date Country
20190116882 A1 Apr 2019 US
Continuations (1)
Number Date Country
Parent 14854968 Sep 2015 US
Child 16049278 US